Market Place
Reply
Comments :
info@indeximinternational.com
Indexim international, are one of the leading supplier, exporter and importer of Pharmaceutical formulation, Novel molecule, APIs, Vet.-APIs, reference standard,, Excipients, Intermediates, Solvents, Vitamins, Nutraceuticals and Dietary supplements. Regulatory documents service etc.
We are exporting several of our products to Latin American countries, Gulf & Asian countries and also a few products to Australia, UK & USA.
We are also contract manufacturer of APIs and attached is the list of products and by cooperation with other manufacturers in India . Also most of the products are from WHO cGMP , ISO , GMP manufacturers.
Indexim International
sales.indeximinternational@gmail.com
info@indeximinternational.com
Mobile:- +91-9033215377
GSTN-24AADFI5767R1ZO
vishvesh.shaishav@gmail.com
We are a one of the leading Indian manufacturer, supplier, importer, dealer, distributor, trader, exporter that is used in pharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, additives, contract manufacturing, chemical compound for pharmaceutical and chemicals process industry available at best price
We are exporting several of our products to Latin American countries, Gulf & Asian countries and also a few products to Australia, UK & USA.
Regulatory documents service etc.
Vishvesh.shaishav@gmail.com
regeneration.margali@gmail.com
Dear Colleagues !
The best method of treatment is to maintain natural mechanisms of recovery and activation of innate resources. Our natural regenerating products are the proof of that.
There are no analogues to our natural regenerating medicines in any R&D of the world's pharmaceutical companies., as today the focus of company development has shifted to biotechnology and genetic engineering.
We are the developers of unique regenerations drugs, which provides a comprehensive regeneration on various problem areas of a human.
For example, these regeneration products are extremely effective in treatment of liver cirrhosis of various etiologies previously officially considered incurable. They are also effective against genital herpes virus, social serious diseases such as B, C, and D viral hepatitis, pulmonary tuberculosis including MDR TB/ XDR TB, lymphosarcoma, fibroma, myoma and pyelonephritis. The drugs prevent diabetic foot gangrene extremities. After the therapy patients no longer need previously recommended heart bypass surgery. The regenerating products restore pancreatic function, give a complete restoration of long-term erectile dysfunction. Replenishes the deficiency of gland and sulfur in the body. The condition of patients with Alzheimer's disease, Down's syndrome, encephalopathy, encephalitis and other diseases improves significantly without any side effects. This is only what we have studied so far. The drugs have a strong antifibrotic effect, they dissolve scars on heart after myocardial infarction. Heart tissue completely regenerates within 6 months.
According to various estimates, there are 300-500 million virus carriers for hepatitis B D in the world. You can imagine the scale of the possible business and the benefits to society, because no one has registered effective drugs.
We are absolutely positive and have no doubt that in the future studies this list will only increase and cover a number of serious nosologies, including those considered incurable.
The entire composition of the products is available in the Pharmacopoeia, which will simplify and speed up their registration. The studies have been going on for more than 25 years and there are no analogues in the world either in action or in composition. The new drugs is protected by patents in several countries and consists only of minerals and medicinal herbs with its know-how technology, which provides unique regenerative abilities. Market volume is estimated at billions of dollars.
In the early studies the regenerating products showed a positive effect in experiments with several types of serious viral infections. Therefore, we have good grounds to believe that they can show high efficiency with new types. The regenerating product is active against RNA and DNA viruses.
We have no doubt that in the long run our unique regenerating products will save millions of lives and increase company's capitalization, which will provide dynamic profits and investment attractiveness.
Published clinical study of our early drug "Margali" https://www.elibrary.ru/item.asp?id=21012483.
Publication in the famous newspaper "Arguments and Facts" in 1996 https://aif.ru/archive/1646037
BUT, it was a 1st generation drug, now the effectiveness of 5th generation drugs has been increased tenfold, there are absolutely no side effects, the time of exposure to the patient's body has been reduced, for example, a 6-month course of treatment replaces liver transplantation surgery for cirrhosis. In 2012, we registered 4 completely new biologically active additives in Kazakhstan, of which 2 drugs in 2016 we registered as a medicine in Georgia.
To confirm the high effectiveness of our drugs, we can offer to conduct a joint clinical study in animals.
Experimental simulation of liver cirrhosis and toxic hepatitis takes usually no longer than 1-2 month.
With mass production, which consequently leads to lower prices, many companies will lose their market share.
We propose to consider cooperation (nutraceutical products, special products, dietary supplements, biologically active additives).
The R&D department has more than 30 drugs.
There are no analogues in the world and will never be.
https://margali-ltd.com
